WuXi Biologics (Cayman) Inc 2021 SR
The report highlights WuXi Biologics' 2021 ESG performance, marking its tenth anniversary. The company established a medium-to-long-term GHG emissions target to reduce Scope 1 and 2 intensity by 50% by 2030. It achieved an 8% year-on-year decrease in GHG emissions intensity and a 13% reduction in water consumption intensity, largely through the use of single-use technology. Socially, the company maintained a workforce of over 10,000 employees with 53% women and contributed over 3,000 volunteer hours. Governance was strengthened through the establishment of an ESG Committee and ISO 27001 certification for information security.
Company: WuXi Biologics (Cayman) Inc
Sector: Health Care
Country: China
Year: 2021
Type: SR
Pages: 57
WuXi Biologics (Cayman) Inc
ESG Report
The report highlights WuXi Biologics' 2021 ESG performance, marking its tenth anniversary. The company established a medium-to-long-term GHG emissions target to reduce Scope 1 and 2 intensity by 50% by 2030. It achieved an 8% year-on-year decrease in GHG emissions intensity and a 13% reduction in water consumption intensity, largely through the use of single-use technology. Socially, the company maintained a workforce of over 10,000 employees with 53% women and contributed over 3,000 volunteer hours. Governance was strengthened through the establishment of an ESG Committee and ISO 27001 certification for information security.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Mar 22, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees